Read
- Whole neighborhoods razed by Oklahoma tornado that killed 24
|
- Analysis: Some Republicans see new scandal in Sebelius fundraising
- Apple CEO makes no apology for company's tax strategy
|
- Convicted U.S. killer Arias would join tiny death row group
- Drop in U.S. underground water levels has accelerated -USGS
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Devastated by tornado
A huge tornado tears through the Oklahoma City suburb of Moore, killing dozens. Slideshow
Nuclear tsunami wall
Safety upgrades designed to prevent a repeat of the Fukushima disaster. Slideshow
Sponsored Links
Vascepa awaits FDA nod on marketing exclusivity
(Reuters) - Amarin Corp said the U.S. health regulator is yet to decide on granting exclusive marketing rights to its heart drug Vascepa, sending its shares down 3 percent In extended trading.
Based on its talks with the U.S. Food and Drug Administration, Amarin does not expect the FDA's Orange Book Supplement to include an entry with respect to the regulatory exclusivity status of Vascepa. the company said.
The FDA publishes an Orange Book, which includes details of recently approved products, patent and exclusivity information.
Vascepa, which would compete with GlaxoSmithKline Plc's Lovaza, serves as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.
Shares of the Ireland-based company were down at $14 in extended trading. They closed at $14.41 on the Nasdaq on Monday.
(Reporting By Pallavi Ail in Bangalore; Editing by Joyjeet Das)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters